An Overview of the Advances in Research on the Molecular Function and Specific Role of Circular RNA in Cardiovascular

Lianli Yin1, Yinghua Tang2, Yulin Yuan1

  • 1Department of Clinical Laboratory, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021 Guangxi, China.

Insights

Circular RNAs (circRNAs) are emerging as key players in cardiovascular disease (CVD). Dysregulated circRNA expression is linked to CVD development and complications, offering new diagnostic and therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally, with China reporting the highest death rates.
  • Circular RNAs (circRNAs), structurally stable closed-loop transcripts, are increasingly recognized for their regulatory roles in eukaryotes.
  • Emerging evidence links aberrant circRNA expression to metabolic diseases, including hypertension and CVD.

Purpose of the Study:

  • To review the current understanding of circRNAs in the context of cardiovascular disease.
  • To elucidate the role of circRNAs as potential biomarkers for CVD and related conditions.
  • To propose novel research strategies for analyzing circRNAs in cardiovascular medicine.

Main Methods:

  • Literature review of studies on circRNA expression and function in cardiovascular disease.
  • Analysis of existing research on circRNAs as microRNA sponges and RNA-binding proteins.
  • Synthesis of findings linking circRNA dysregulation to CVD pathogenesis and complications.

Main Results:

  • CircRNAs exhibit distinct tissue specificity and are widely distributed in eukaryotes.
  • Dysregulated circRNA expression is an early indicator in metabolic diseases like hypertension and CVD.
  • CircRNAs contribute to cardiovascular complications and serve as potential biomarkers.

Conclusions:

  • CircRNAs represent a significant area of research for understanding CVD mechanisms.
  • Innovative biomarkers based on circRNAs can aid in the diagnosis and management of cardiovascular events.
  • Further analysis of circRNAs offers new strategies for medical research in cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.6K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
22
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
290